Latest Capital Raising News

Biotron Limited has successfully raised $1.27 million through an entitlement issue to fund its antiviral drug development, including a promising Hepatitis B compound that cleared its initial animal safety study.

Lion Energy Limited reported a net cash outflow in Q2 2025 but maintains a solid cash position of AUD 2.13 million alongside a convertible note facility, signaling cautious optimism for its exploration activities.

Octava Minerals has secured a binding agreement to acquire the Federation Cu-Zn-Ag Project in Tasmania, reported promising bioleaching test results at its Byro REE-Li Project, and raised $1.5 million to fund exploration and working capital.

Rey Resources reports continued exploration progress in Western Australia's Canning Basin alongside a stable financial footing supported by substantial shareholder loans.

Tennant Minerals has identified a significant copper anomaly at its Bluebird East prospect, mirroring the high-grade Bluebird discovery, while advancing large-scale gold-copper targets at its Barkly Project in the Northern Territory.

Mount Burgess Mining advances metallurgical test work at its Nxuu deposit, navigates leadership changes, and pursues a significant legacy debt extinguishment as it refines its strategic focus.

Chimeric Therapeutics has advanced its CHM CDH17 CAR-T program with dose escalation and FDA Fast Track status, alongside promising early results in AML trials and a successful $6.6 million capital raise.

Aurora Energy Metals has secured a six-month extension on Eagle Energy Metals' exclusive option for its flagship uranium project, accompanied by significant cash inflows and advancing metallurgical work. The company ends the quarter debt-free with a solid cash buffer as it pushes forward on multiple fronts.

Hydrocarbon Dynamics Limited reported ongoing sales and expanded trials of its HCD Multi-Flow product worldwide, alongside plans for a fully underwritten rights issue to bolster its financial position.

Saturn Metals has reported a robust June quarter highlighted by significant drilling success and exceptional metallurgical recoveries at Apollo Hill, lifting its gold resource to 2.24 million ounces. These developments set the stage for a pivotal Pre-Feasibility Study and maiden Ore Reserve later this year.

Mithril Silver and Gold reports outstanding high-grade gold and silver assay results from its Copalquin district in Mexico, setting the stage for an extensive drilling campaign starting August 2025. The discovery at Target 6 expands the district’s promising resource potential.

Prescient Therapeutics has raised $6.8 million through a Share Purchase Plan to fund the Phase 2 development of its novel cancer therapy PTX-100, while launching a discounted placement to sophisticated investors.